Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

Needham analyst Ryan MacDonald maintained a Buy rating on Veeva Systems (VEEV – Research Report) today and set a price target of $270.00.Stay ...

In the most recent trading session, Veeva Systems (VEEV) closed at $214.75, indicating a +1.43% shift from the previous trading day.

According to Benzinga Pro, Veeva Systems's peer group average for short interest as a percentage of float is 5.98%, which ...

Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Veeva Systems (NYSE:VEEV – Get Free Report) had its price objective decreased by equities research analysts at Truist ...

Highlights,Veeva Systems’ stock price decreased by 2.2% recently.,The company provides cloud-based software solutions for the life sciences sector.,Truist Financial lowered Veeva's price target to ...

Veeva Systems (NYSE:VEEV – Free Report) had its price target cut by KeyCorp from $285.00 to $255.00 in a research note issued ...

Veeva share price has recently been battling concerns that Salesforce will become a more aggressive competitor and take ...

I am bullish on Veeva's growth prospects, with 40% potential upside, making it one of my top software stock picks for 2025.

In a report released today, Craig Hettenbach from Morgan Stanley maintained a Sell rating on Veeva Systems (VEEV – Research Report), with a ...